All Stories

  1. Invariant NKT cells are pathogenic in the HLA-DR4-transgenic humanized mouse model of toxic shock syndrome and can be targeted to reduce morbidity
  2. Microbiome Regulation of Autoimmune, Gut and Liver Associated Diseases
  3. IL-22, cell regeneration and autoimmunity
  4. Reciprocity in Microbiome and Immune System Interactions and its Implications in Disease and Health
  5. Suppression of Immunodominant Antitumor and Antiviral CD8+ T Cell Responses by Indoleamine 2,3-Dioxygenase
  6. Vasostatin-1 antigenic epitope mapping for induction of cellular and humoral immune responses to chromogranin A autoantigen in NOD mice
  7. Prevention of Type 1 Diabetes and Its Recurrence by Immunotherapy with Mycobacterial Adjuvants
  8. List of Contributors
  9. The involvement of interleukin-22 in the expression of pancreatic beta cell regenerative Reg genes
  10. Research Highlights: Highlights from the latest articles in immunotherapy
  11. The Early Inflammatory Response in a Mini–Cardiopulmonary Bypass System
  12. Immunomodulation and Regeneration of Islet Beta Cells by Cytokines in Autoimmune Type 1 Diabetes
  13. Junctional diversity prevents negative selection of an antigen-specific T cell repertoire
  14. Research Preparedness Paves the Way to Respond to Pandemic H1N1 2009 Influenza Virus
  15. Mycobacterial agents such as BCG vaccine prevent inflammation and autoimmune diseases.
  16. Exogenous CLIP localizes into endocytic compartment of cells upon internalization: Implications for antigen presentation by MHC class II molecules
  17. C-terminal apolipoprotein E-derived peptide, Ep1.B, displays anti-atherogenic activity
  18. Plasmacytoid Dendritic Cells Induction by a Self-peptide Ep1.B Derived from Apolipoprotein E Prevent Autoimmune Diabetes
  19. Reduced IFN-α secretion by blood dendritic cells in human diabetes
  20. Role of Donor MHC Class III Genes in the Destruction of Transplanted Islets in NOD Mice
  21. Insulin is specific biomarker for humoral autoimmunity in nonobese diabetic (NOD) mice.
  22. CIHR Research: Taking Down Goliaths: New Vaccines May Spell the End for Ebola, Marburg and Lassa Virus Infections
  23. Polycationic lipids inhibit the pro-inflammatory response to LPS
  24. Gene expression profiling in type 1 diabetes prone NOD mice immunized with a disease protective autoantigenic peptide
  25. Mechanism of modulation of T cell responses by N-palmitoylated peptides
  26. Characterization of the Role of Major Histocompatibility Complex in Type 1 Diabetes Recurrence after Islet Transplantation
  27. Innovation and Challenges in Funding Rapid Research Responses to Emerging Infectious Diseases: Lessons Learned from the Outbreak of Severe Acute Respiratory Syndrome
  28. Characterization of Dendritic Cells in Humans with Type 1 Diabetes
  29. CD4+CD25+regulatory T cells generated in response to insulin B:9–23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells
  30. Type 1 diabetes alters anti-hsp90 autoantibody isotype
  31. Chimerism of Murine Fetal Bone Marrow by Maternal Cells Occurs in Late Gestation and Persists into Adulthood
  32. Myeloid Dendritic Cells in Non-Obese Diabetic Mice have Elevated Costimulatory and T Helper-1-Inducing Abilities
  33. TRANSPLANTED MHC CLASS I-DEFICIENT NONOBESE DIABETIC MOUSE ISLETS ARE PROTECTED FROM AUTOIMMUNE INJURY IN DIABETIC NONOBESE RECIPIENTS1
  34. SINGLE INJECTION OF INSULIN DELAYS THE RECURRENCE OF DIABETES IN SYNGENEIC ISLET-TRANSPLANTED DIABETIC NOD MICE 1
  35. The functional role of class II-associated invariant chain peptide (CLIP) in its ability to variably modulate immune responses
  36. Preferential Proliferation and Differentiation of Double-Positive Thymocytes into CD8+ Single-Positive Thymocytes in a Novel Cell Culture Medium
  37. B7/CD28 Costimulation Is Essential for the Homeostasis of the CD4+CD25+ Immunoregulatory T Cells that Control Autoimmune Diabetes
  38. Stimulation of the Developing Immune System Can Prevent Autoimmunity
  39. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection
  40. Immune Mechanisms that Regulate Susceptibility to Autoimmune Type I Diabetes
  41. Leukocytes Utilize Both α4 andα5 Integrins for Intraislet Infiltration in Non-obese Diabetic Mice
  42. ABSENCE OF DONOR MHC CLASS I BUT NOT CLASS II PREVENTS AUTOIMMUNE INJURY OF TRANSPLANTED ISLETS IN DIABETIC NOD MICE
  43. Mechanisms of induction of renal allograft tolerance in CD45RB-treated mice
  44. Epitope dominance: evidence for reciprocal determinant spreading to glutamic acid decarboxylase in non-obese diabetic mice
  45. Protective and destructive effects of microbial infection in insulin-dependent diabetes mellitus
  46. Characterization of Novel T-cell Epitopes on 65kDa and 67kDa Glutamic Acid Decarboxylase Relevant in Autoimmune Responses in NOD Mice
  47. Development of an I-Ag7-expressing Antigen-presenting Cell Line: Intrinsic Molecular Defect in Compact I-Ag7Dimer Generation
  48. The Nonobese Diabetic Mouse as a Model of Autoimmune Diabetes: Immune Dysregulation Gets the NOD
  49. BCG Vaccination Prevents Insulin-Dependent Diabetes Mellitus (IDDM) in NOD Mice after Disease Acceleration with Cyclophosphamide
  50. Characterization of immunodominant peptide determinants of iddm-associated autoantigens in the nod mouse
  51. Suppression of experimental allergic encephalomyelitis in the Lewis rat, by administration of an acylated synthetic peptide of myelin basic protein
  52. Modulation and Detection of IDDM by Membrane Associated Antigens from the Islet Beta Cell Line NIT-1
  53. CD28/B7 Regulation of Th1 and Th2 Subsets in the Development of Autoimmune Diabetes
  54. Immune responses to self peptides naturally presented by murine class II Major Histocompatibility Complex molecules
  55. VLA-β1 Integrin Subunit-Specific Monoclonal Antibodies MB1.1 and MB1.2: Binding to Epitopes Not Dependent on Thymocyte Development or Regulated by Phorbol Ester and Divalent Cations
  56. Peptide analogs with different affinities for MHC alter the cytokine profile of T helper cells
  57. Do serum antibodies to heat-shock protein 65 relate to age or stroke?
  58. LONG-TERM SURVIVAL OF SYNGENEIC ISLET GRAFTS IN BCG-TREATED DIABETIC NOD MICE CAN BE REVERSED BY CYCLOPHOSPHAMIDE
  59. LONG-TERM SURVIVAL OF SYNGENEIC ISLET GRAFTS IN BCG-TREATED DIABETIC NOD MICE CAN BE REVERSED BY CYCLOPHOSPHAMIDE
  60. Immunization With the Larger Isoform of Mouse Glutamic Acid Decarboxylase (GAD67) Prevents Autoimmune Diabetes in NOD Mice
  61. Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice
  62. Effect of anti-interferon-γ monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains
  63. Lewis Rat T Cells Can Reutilize, Process, and Present Myelin Basic Protein to Antigen-Specific T Cell Lines
  64. BCG IMMUNOTHERAPY PREVENTS RECURRENCE OF DIABETES IN ISLET GRAFTS TRANSPLANTED INTO SPONTANEOUSLY DIABETIC NOD MICE
  65. A novel role for the immunogenic peptides in the assembly and expression of class II MHC molecules on B lymphocytes
  66. Elucidation of peptide conformation involved in the recognition of (EYA)5, EYK(EYA)4 and EYAEAA(EYA)3 peptides by MHC class II molecules and T-cell receptor
  67. Microbial Agents and Autoimmune Diabetes
  68. Evidence for immunodominance between closely related epitopes in the selection of T cell repertoire: Hierarchy of T cell epitopes in a repeating sequence
  69. Variable region peptides of the T cell receptor beta chain block superantigens
  70. Unusually diverse T cell response to a repeating tripeptide epitope
  71. Regulation of immune responses by peptides of T-cell receptor variable region
  72. Epitopes of human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins recognized by antibodies in the sera of HIV-1-infected individuals
  73. Role of the first external domain of I-Aβ chain in immune responses and diabetes in non-obese diabetic (NOD) mice
  74. Critical role of an amino acid residue in a T cell determinant is due to its interaction with a neighboring non-critical residue
  75. Characterization of agretopes and epitopes involved in the presentation of beef insulin to T cells
  76. Prediction of the secondary structure and functional sites of major histocompatibility complex molecules
  77. Functional degeneracy of residues in a T cell peptide epitope contributes to its recognition by different T cell hybridomas
  78. Contribution of antigen processing to the recognition of a synthetic peptide antigen by specific T cell hybridomas
  79. Recognition of peptide antigens by T-lymphocytes
  80. Treatment of Diabetic (db/db) Mice with Anti-Class-II MHC Monoclonal Antibodies
  81. Fine-specificity analysis of antibodies directed to the C-terminal peptides of cytochrome c recognized by T-lymphocytes
  82. A new ?marker? protein for astrocytes
  83. ChemInform Abstract: IMMUNODOMINANT REGIONS OF TRANSPLANTATION ANTIGENS: SYNTHESIS AND ANTIGENICITY OF A DETERMINANT IN THE FIRST DOMAIN OF H-2K MOLECULE
  84. Antigen-Specific T-Cell Activation
  85. Gene conversion may be responsible for the generation of the alloreactive repertoire
  86. Insulin: carrier potential for enzyme and drug therapy
  87. FATE OF ANTIPATERNAL H-2 ANTIBODIES BOUND TO THE PLACENTA IN VIVO
  88. Monoclonal antibody definition of sperm — specific antigen crossreactivity between sea urchin and mammals
  89. Monoclonal antibodies as probes for antigens of biological significance to the materno fetal relationship
  90. CHARACTERIZATION AND CROSS-REACTIVITY OF HUMAN AND MOUSE ONCOFETAL ANTIGENS USE OF A NEW SOLID PHASE ASSAY FOR DETECTION OF CELL SURFACE ANTIGENS
  91. Protection and prevention
  92. Antigen recognition. V. Requirement for histocompatibility between antigen-presenting cell and B cell in the response to a thymus- dependent antigen, and lack of allogeneic restriction between T and B cells
  93. Monoclonal antibodies to oncofetal antigens
  94. Ontogeny & kinetics of the placental immunoabsorbent barrier
  95. An activity derived from rabbit serum causing interruption of pregnancy in normal mice
  96. Monoclonal antibodies showing sequence specificity in their interaction with single-stranded DNAs
  97. Quantitation of the capacity of the mouse placenta to absorb monoclonal anti-fetal H-2K antibody
  98. MHC control of T lymphocyte-macrophage interactions
  99. Peptides-XXXIV
  100. Peptides—XXXVII
  101. Peptides—XXXV
  102. RESTRAINTS ON CURRENT CONCEPTS OF SELF-TOLERANCE
  103. Histocompatibility typing by cellular radioimmunoassay
  104. Synthetic polypeptide antigens of defined geometry
  105. The structure of carindone
  106. Structure of asclepin and some observations on the NMR spectra of Calotropis glycosides
  107. Cardenolides—glycosides and genins
  108. A reinvestigation of the triterpenes of Centella asiatica
  109. Steroids and triterpenes from Alangium lamarckii, Allamanda cathartica, Abrus precatorius and Holoptelea integrifolia
  110. Chemical examination of Centella asiatica linn—III